Literature DB >> 15728505

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.

Charles F Anderson1, Susana Mendez, David L Sacks.   

Abstract

Experimental Leishmania major infection in mice has been of immense interest because it was among the first models to demonstrate the importance of the Th1/Th2 balance to infection outcome in vivo. However, the Th2 polarization that promotes the development of nonhealing cutaneous lesions in BALB/c mice has failed to adequately explain the mechanisms underlying nonhealing forms of leishmaniasis in humans. We have studied a L. major strain from a patient with nonhealing lesions that also produces nonhealing lesions with ulcerations and high parasite burden in conventionally resistant C57BL/6 mice. Surprisingly, these mice develop a strong, polarized, and sustained Th1 response, as evidenced by high levels of IFN-gamma produced by Leishmania-specific cells in the draining lymph node and in the ear lesion, and an absence of IL-4 or IL-13. The parasites fail to be effectively cleared despite high level induction of inducible NO synthase in the lesion, and despite their sensitivity to killing by IFN-gamma-activated macrophages in vitro. Infection of IL-10(-/-) mice, blockade of the IL-10R, or depletion of CD25(+) cells during the chronic phase promotes parasite killing, indicating that IL-10 and regulatory T cells play a role in rendering the Th1 responses ineffective at controlling infection in the skin. Mice with nonhealing primary lesions are nonetheless resistant to reinfection in the other ear. We suggest that nonhealing infections in animal models that are explained not by aberrant Th2 development, but by overactivation of homeostatic pathways designed to control inflammation, provide better models to understand nonhealing or reactivation forms of leishmaniasis in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728505     DOI: 10.4049/jimmunol.174.5.2934

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Qualitative and quantitative immunohistochemical evaluation of iNOS expression in the spleen of dogs naturally infected with Leishmania chagasi.

Authors:  Fernando Rocha dos Santos; Paula Melo Abreu Vieira; Rodrigo Correa-Oliveira; Rodolfo Cordeiro Giunchetti; Claudia Martins Carneiro; Alexandre Barbosa Reis; Luiz Cosme Cotta Malaquias
Journal:  Parasitol Res       Date:  2010-12-29       Impact factor: 2.289

Review 2.  Inflammasomes and Leishmania: in good times or bad, in sickness or in health.

Authors:  Dario S Zamboni; David L Sacks
Journal:  Curr Opin Microbiol       Date:  2019-06-20       Impact factor: 7.934

3.  Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Silvia E Z Vidal; Sylvie Bertholet; Rhea N Coler; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2009-03-09       Impact factor: 3.641

Review 4.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

6.  Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.

Authors:  Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

9.  Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.

Authors:  Deborah E Dobson; Shaden Kamhawi; Phillip Lawyer; Salvatore J Turco; Stephen M Beverley; David L Sacks
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

10.  Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro.

Authors:  B-S Choi; P Kropf
Journal:  Parasite Immunol       Date:  2009-04       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.